Whenever we do anything that connects us with our inner being, we feel fulfilled. This inner fulfilment is what gives us true joy and peace.
When we do anything to help someone, we intend to make them comfortable and add joy to their lives. Good intention is a great driving force in life. The goodness we hold in our hearts always comes back to us in bigger and better ways.
Always try to add joy to other people's life. You will find even more reasons to smile.
Success is never achieved alone. There are always people behind us who help us to get where we want.
Sometimes, when people achieve success, they feel so powerful that they find everyone else too small. They don't acknowledge that what's making them feel powerful is not their success but the power of the people who had supported them. This power stays only when we acknowledge their guidance, wishes and presence in our lives.
Acknowledge and appreciate those who have helped you in your life. You will create success that will last.
Planning is a great way to foresight and manage the ups and downs that you may face . However cautious and thorough planning it may be, plans do fail at times.
When a plan fails, most people are unable to accept it. This is because most plans are designed to be fixed, allowing little or no room for changes or adjustment. When things take an unexpected turn, people feel they lack the capability to handle them.
Whether your plan is big or small or at the starting stage or near to completion, if ever it fails, don't lose heart. Calm your mind, reassess it and think of new ways to go about it.
Onye ọ bụla na-emehie ihe, ma ọtụtụ ndị na-ala azụ ịnakwere ha. Site n'ịhapụ mmejọ anyị, anyị na-ewepụ ohere anyị ịmụta na imeziwanye.Mgbe ụfọdụ, ọ bụrụgodị na ebumnobi anyị kacha mma, ihe na-aga nke ọma. Mgbe anyị matara na anyị mehiere, ọtụtụ n'ime anyị na-agbachitere onwe anyị. Anyị na-atụ ụjọ ịnakwere ihe anyị mejọrọ ga-eme ka anyị na-ada ndị ọzọ n’ihu, n’ihi ya, anyị na-agọnahụ ya. Ọ bụghị nanị na ime nke a na-emebi mmekọrịta anyị kamakwa ọbụna ito eto anyị.
Iji too na ndụ, lelee ụzọ ị ga-esi mee ka onwe gị ka mma. Ọganihu nwere ike ime naanị mgbe ị ghọtara adịghị ike gị ma dị njikere ịrụ ọrụ na ha.
The theme for World AIDS Day 2022 is Equalize, highlighting the critical need to address inequalities that are holding back progress.
CHAI was founded 20 years ago in response to the global AIDS crisis. At the time, many believed AIDS was an insurmountable problem. But over the last two decades, together with governments, partners, and communities of people living with HIV, we have scaled lifesaving treatment globally to over 28 million people – a feat once thought impossible.
At the beginning of this century, treating HIV cost over US$10,000 per person per year. CHAI’s pioneering work negotiating price reductions and generic licenses, together with critical efforts from partners like PEPFAR, the Global Fund, and Unitaid, has dramatically reduced the price of treatment to under US$50 per person per year today.
As
a result, the outlook for adults and children living with HIV is far
better. Yet work remains to ensure that everyone has equal access to the
care they need. Here are three ways that we are closing the HIV equity
gap in 2022 and beyond.
Cryptococcal meningitis is the second leading cause of death in people living with HIV. Prior to the Unitaid-CHAI Optimal grant
fluconazole was the only drug available to treat cryptococcal
meningitis in many low- and middle-income countries, despite
considerable evidence it is associated with suboptimal patient outcomes.
Fluconazole monotherapy leads to an unacceptably high mortality rate of
over 50 percent at just 10 weeks, compared to the optimal combination
therapy of flucytosine (5FC) and liposomal amphotericin (L-AmB) – which
cuts the mortality rate in half. Through Unitaid and CHAI’s catalytic
procurement and support to governments, 5FC and L-AmB are now available
in Uganda and across project focal countries.
Among the 1.7 million children living with HIV today, almost half are not on life-saving treatment, viral suppression among children is very low compared to adults, and persistent geographic disparities remain. Without rapid action, these alarming inequities put children at greater risk of AIDS-related mortality.
But there is hope. HIV treatment for children has dramatically improved over the past year and a half thanks to a Unitaid and CHAI-led partnership to
develop better medication. As a result of this partnership, the best
available medicine for children (pDTG) has made its way into the hands
of over 100,000 children in over 60 countries after being developed in record-breaking time.
CHAI is supporting government partners in Benin, Nigeria, and Uganda to
conduct research on the use of pDTG to treat children in real world
settings.
Reductions in HIV infections have stubbornly stagnated in recent years. Key and priority populations remain at disproportionate and high risk of infection. Encouragingly, the portfolio of HIV prevention options is expanding, positioning us for transformation. The injectable cabotegravir (CAB-LA) received US FDA approval in December 2021, and throughout 2022, CHAI worked closely with a range of stakeholders, including donors, communities, ViiV, and generic manufacturers to accelerate access to CAB-LA for those who need it most.
However,
impact for those in greatest need of HIV prevention options is still
not guaranteed. Urgent, coordinated action is needed to support
well-designed and timely evidence generation as well as market shaping,
programmatic, and demand generation interventions to convert potential
to impact.